L-arginine and α-ketoglutarate in a 2:1 ratio are primarily used as a physical enhancement supplement.
A clinically studied nitric oxide booster combining two molecules of L-Arginine with one molecule of Alpha-Ketoglutarate — engineered for maximum bioavailability, explosive muscle pumps, and superior athletic performance.
L-Arginine Alpha-Ketoglutarate 2:1 (AAKG) is a synergistic compound formed by binding two molecules of the semi-essential amino acid L-Arginine with one molecule of Alpha-Ketoglutarate (AKG) — a key intermediate of the Krebs cycle. This specific 2:1 molecular ratio is optimized to enhance the functional benefits and bioavailability of both components, making it one of the most effective forms of arginine supplementation available in sports nutrition.
L-Arginine serves as the primary substrate for nitric oxide synthase (NOS), the enzyme responsible for producing nitric oxide (NO) — a powerful vasodilator that relaxes blood vessels and increases blood flow to muscles. Meanwhile, Alpha-Ketoglutarate directly participates in cellular energy (ATP) production through the Krebs cycle and has demonstrated roles in ammonia detoxification and muscle protein synthesis. Together, these components create a compound that addresses both performance and recovery at the metabolic level.
L-Arginine AKG 2:1 delivers multi-pathway support for athletes seeking a nitric oxide booster that goes beyond simple vasodilation.
As a potent nitric oxide precursor, L-Arginine AKG fuels the NOS enzyme pathway, boosting endogenous NO synthesis. Nitric oxide relaxes vascular smooth muscle, causing vasodilation and dramatically increased blood flow to working muscles. The result: skin-splitting muscle pumps, enhanced vascularity, and superior nutrient delivery during high-intensity training.
Álvarez et al., Nitric Oxide, 2020In a controlled 8-week study, trained men supplementing with 12g daily of AAKG combined with resistance training showed significant improvements in 1RM bench press and peak power output. AAKG has also been demonstrated to favorably modulate post-exercise hormonal profiles, including elevated testosterone and reduced cortisol during recovery.
Campbell et al., Int J Sport Nutr Exerc Metab, 2006The Alpha-Ketoglutarate component feeds directly into the Krebs cycle, optimizing mitochondrial ATP production and supporting sustained aerobic energy output. By enhancing oxygen delivery via NO-mediated vasodilation and fueling oxidative phosphorylation, AAKG 2:1 helps delay the onset of fatigue during prolonged endurance efforts.
Owczarek et al., Nutrients, 2024Alpha-Ketoglutarate facilitates the clearance of ammonia — a toxic byproduct of intense exercise that contributes to central fatigue. Recent narrative reviews highlight AKG's positive role in skeletal muscle health, including the attenuation of muscle atrophy and promotion of muscle regeneration through satellite cell activation and protein synthesis pathways.
Rinschen et al., J Mol Med, 2024L-Arginine is converted by nitric oxide synthase (NOS) into nitric oxide (NO) and L-citrulline. NO signals vascular smooth muscle to relax, increasing vessel diameter and blood flow to working muscles.
Alpha-Ketoglutarate enters the Krebs (TCA) cycle as a direct substrate, driving oxidative phosphorylation and mitochondrial ATP synthesis for sustained cellular energy output.
AKG accepts amino groups via transamination, converting toxic ammonia into glutamate and glutamine — supporting nitrogen balance, reducing exercise-induced fatigue, and accelerating recovery.
Based on clinical research protocols. Individual needs may vary based on body weight, training intensity, and health status. Start with the lower end to assess tolerance.
| Goal | Daily Dosage | Timing | Duration |
|---|---|---|---|
| Muscle Pump & Pre-Workout | 3 – 6 g | 30 – 45 min before training | Training days |
| Athletic Performance | 6 – 12 g (divided) | Pre-workout & post-workout | 8 – 12 week cycles |
| General Wellness | 2 – 3 g | Once daily, with a meal | Ongoing |
| Recovery Support | 3 – 6 g | Post-workout or before bed | Training days |
The efficacy of L-Arginine AKG 2:1 is supported by peer-reviewed studies across sports performance, metabolic health, and longevity research.
8-week randomized, double-blind, placebo-controlled study investigating AAKG supplementation (12g/day) combined with 4-day/week resistance training in trained adult males.
Assessed hormonal and metabolic effects of AAKG during prolonged endurance exercise and recovery in trained athletes.
Landmark study investigating CaAKG effects on lifespan and health metrics in aging C57BL/6 mice.
Comprehensive review synthesizing evidence on AKG's role in skeletal muscle physiology, protein metabolism, satellite cell function, and muscle wasting.
L-Arginine AKG 2:1 is a versatile raw material suitable for a wide range of supplement delivery formats and product categories.
Core ingredient for nitric oxide-boosting pre-workout blends. Pairs synergistically with caffeine, citrulline, and beta-alanine.
Rapid dissolution, improved taste, and convenient dosing. Excellent bioavailability makes this a consumer-preferred format.
Standard encapsulation for daily supplementation routines. Suitable for standalone and multi-ingredient formulas.
High water solubility makes AAKG ideal for intra-workout beverages designed to sustain blood flow during training.
Combine with BCAAs, creatine, and electrolytes for comprehensive formulas targeting serious athletes.
Leveraging AKG's emerging research in lifespan and healthspan for healthy aging and metabolic wellness positioning.
Intended for use in dietary supplements, functional foods, and sports nutrition products.
Not intended for direct retail sale to consumers.
L-Arginine Alpha-Ketoglutarate 2:1 (AAKG) is a compound formed by binding two molecules of L-Arginine with one molecule of Alpha-Ketoglutarate. L-Arginine serves as the primary substrate for nitric oxide synthase (NOS), which produces nitric oxide (NO) — a potent vasodilator that increases blood flow to muscles. The Alpha-Ketoglutarate component supports Krebs cycle energy production and ammonia clearance, creating a dual-action compound for both performance and recovery.
Clinical research protocols have used doses ranging from 3g to 12g per day, divided into multiple servings around training sessions. For muscle pump and pre-workout benefits, 3–6g taken 30–45 minutes before training is commonly recommended. For athletic performance, 6–12g daily over 8–12 week cycles has been studied. Always start with a lower dose (3g) to assess tolerance.
Key evidence-based benefits include: (1) Enhanced nitric oxide production for improved muscle pumps and vascularity, (2) Improved maximal strength and power output during resistance training, (3) Better endurance through optimized aerobic energy metabolism, (4) Faster recovery via ammonia clearance and favorable hormonal modulation (increased testosterone, reduced cortisol), and (5) Emerging evidence for AKG's role in healthy aging and muscle preservation.
While regular L-Arginine provides only the amino acid, L-Arginine AKG 2:1 combines it with Alpha-Ketoglutarate in a 2:1 molecular ratio. The AKG component enhances bioavailability, supports Krebs cycle energy production, facilitates ammonia detoxification, and has been independently studied for its roles in muscle protein synthesis and longevity — making AAKG 2:1 a more comprehensive supplement than plain L-Arginine.
L-Arginine AKG 2:1 is generally considered safe for healthy adults at recommended doses. An 8-week clinical trial using 12g/day showed no adverse effects on blood lipids, glucose, or renal function. However, individuals with pre-existing conditions (cardiovascular disease, herpes, kidney impairment), those taking medications (nitrates, antihypertensives), and pregnant or nursing women should consult a healthcare professional before use.
Yes. Popular stacks include: L-Citrulline (extended NO production via the citrulline-NO cycle), Creatine Monohydrate (strength and power), Beta-Alanine (endurance buffering), Caffeine (energy and focus), and BCAAs/EAAs (muscle protein synthesis and recovery). When formulating, account for total L-Arginine intake from all sources in dosage calculations.
L-Arginine AKG 2:1 is available as a fine white crystalline powder, suitable for hard-shell capsules, tablets, effervescent tablets (rapid dissolution, improved palatability), or flavored drink powders. Its high water solubility makes it particularly well-suited for effervescent and ready-to-mix beverage formats. Custom particle sizes and granulation options are available from GMP-certified manufacturers.
| COA | ||||||||||||||||
| Product Name | L-Arginine Alpha Ketoglutarate 2:1 | |||||||||||||||
| Batch No. | 20250312 | Batch Size | 1000KG | |||||||||||||
| Manu.Date | 2025-03-08 | Expiry Date | 2027-03-07 | |||||||||||||
| ltem | Specification | Resuls | Test method | |||||||||||||
| Identification | HPLC | Positive | HPLC | |||||||||||||
| Appearance | White to yellow Crystalline powder |
White to yellow Crystalline powder |
Visual | |||||||||||||
| Assay(%) | 98～102.0 | 100.66 | HPLC | |||||||||||||
| L-Ariginine(%) | 65.5～69 | 66.52 | HPLC | |||||||||||||
| Alpha Ketoglutarate(%) | 26.5～29 | 27.74 | HPLC | |||||||||||||
| Specific rotation()[a]o²0 (8g/100mL,6N HCI) |
+16.5～+18.5 | 18.1 | USP | |||||||||||||
| PH(10%H₂O) | 5.5～7.0 | 6.0 | USP | |||||||||||||
| Hydrate | ≤6.8 | 6.4 | USP | |||||||||||||
| Chloride(%) | ≤0.05 | 0.03 | USP | |||||||||||||
| Loss on Drying(%) | ≤1.0 | 0.35 | USP | |||||||||||||
| Residue in Ignition (%) | ≤0.2 | 0.10 | USP | |||||||||||||
| Heavy Metals(ppm) | ≤10 ppm | <10 ppm | AAS | |||||||||||||
| As(ppm) | ≤1 ppm | <1 ppm | AAS | |||||||||||||
| Pb(ppm) | ≤1 ppm | <1 ppm | AAS | |||||||||||||
| Cd(ppm) | ≤1 ppm | <1 ppm | AAS | |||||||||||||
| Hg(ppm) | ≤1 ppm | <1 ppm | AAS | |||||||||||||
| Iron(ppm) | ≤10 ppm | <10 ppm | AAS | |||||||||||||
| Bulk density(g/ml) | ≥0.5 | 0.53 | ||||||||||||||
| Particle Size | Thus 30 | 100% | ||||||||||||||
| Total Plate Count (cfu/g) | ≤1000 | <1000 | USP | |||||||||||||
| Yeast(cfu/g) | ≤100 | <100 | USP | |||||||||||||
| Mold (cfu/g) | ≤100 | <100 | USP | |||||||||||||
| E.Coli(cfu/g) | Negative | Not detectable | USP | |||||||||||||
| Salmonella(cfu/g) | Negative | Not detec table |
USP | |||||||||||||
| Staphylococcus Aureus (cfu/g) |
Negative | Not detetable | USP | |||||||||||||
| Melamine and Melamine derivatives |
Free | Free | ||||||||||||||
| Conclusion | Comply with the specifications | |||||||||||||||
Factory View
 |
 |
 |
 |
 |
 |
Our professional sales team is waiting for your consultation.
GET IN TOUCH